BrightSpring Health Services
BTSG · Health Care Services
$60.11
1.2%Quest Diagnostics
DGX · Health Care Services
$241.89
0.6%The short version
- BrightSpring Health Services is the larger business, with $12.9B of revenue in fiscal 2025 against $11.0B for Quest Diagnostics.
- BrightSpring Health Services grew revenue faster (28.2%, against 11.8%).
- Quest Diagnostics kept more of each dollar of sales as operating profit (14.1% operating margin, against 2.3% operating margin).
- Quest Diagnostics turned more of its sales into free cash flow (12.3% FCF margin, against 3.1% FCF margin).
- Quest Diagnostics earned a higher return on the capital invested in it (9.5%, against 5.3%).
- Investors pay more for each dollar of BrightSpring Health Services’s earnings: a P/E of 36.2x against 24.1x for Quest Diagnostics.
| Latest fiscal year | BTSG · FY25 | DGX · FY25 |
|---|---|---|
| Size | ||
| Market cap | $13.2B | $27.1B |
| Revenue | $12.9B | $11.0B |
| Free cash flow | $395M | $1.4B |
| Net income | $191M | $992M |
| Growth | ||
| Revenue growth | 28.2% | 11.8% |
| 5-year growth | — | 3.2% |
| Share count change | 13.9% | 0.0% |
| Profitability | ||
| Gross margin | 11.8% | 33.2% |
| Operating margin | 2.3% | 14.1% |
| Net margin | 1.5% | 9.0% |
| FCF margin | 3.1% | 12.3% |
| Return on capital | 5.3% | 9.5% |
| Return on equity | 10.8% | 14.2% |
| Balance sheet | ||
| Net debt | $2.4B | $5.3B |
| Net debt / EBITDA | 5.3x | 2.5x |
| Dividends and buybacks | $43.2M | $803M |
| Valuation & quality | ||
| P/E | 36.2x | 24.1x |
| Piotroski F-score | 7 | 6 |
FY16
BTSG —
DGX $7.2B
FY17
BTSG —
DGX $7.4B
FY18
BTSG —
DGX $7.5B
FY19
BTSG —
DGX $7.7B
FY20
BTSG —
DGX $9.4B
FY21
BTSG —
DGX $10.8B
FY22
BTSG $7.7B
DGX $9.9B
FY23
BTSG $7.7B
DGX $9.3B
FY24
BTSG $10.1B
DGX $9.9B
FY25
BTSG $12.9B
DGX $11.0B
BTSG
DGX
FY16
BTSG —
DGX 17.7%
FY17
BTSG —
DGX 15.7%
FY18
BTSG —
DGX 14.6%
FY19
BTSG —
DGX 15.9%
FY20
BTSG —
DGX 20.9%
FY21
BTSG —
DGX 22.1%
FY22
BTSG 2.4%
DGX 14.5%
FY23
BTSG 0.8%
DGX 13.6%
FY24
BTSG 1.1%
DGX 13.6%
FY25
BTSG 2.3%
DGX 14.1%
BTSG
DGX
FY16
BTSG —
DGX $823M
FY17
BTSG —
DGX $923M
FY18
BTSG —
DGX $817M
FY19
BTSG —
DGX $843M
FY20
BTSG —
DGX $1.6B
FY21
BTSG —
DGX $1.8B
FY22
BTSG −$74.8M
DGX $1.3B
FY23
BTSG $137M
DGX $864M
FY24
BTSG −$57.1M
DGX $909M
FY25
BTSG $395M
DGX $1.4B
BTSG
DGX
FY16
BTSG —
DGX 9.5%
FY17
BTSG —
DGX 10.7%
FY18
BTSG —
DGX 10.0%
FY19
BTSG —
DGX 10.4%
FY20
BTSG —
DGX 15.7%
FY21
BTSG —
DGX 19.0%
FY22
BTSG —
DGX 11.7%
FY23
BTSG —
DGX 9.9%
FY24
BTSG 2.1%
DGX 9.0%
FY25
BTSG 5.3%
DGX 9.5%
BTSG
DGX
Add another company
Compare up to four at once.
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.